1 / 14

Toxic Hepatocellular Injury

Toxic Hepatocellular Injury. Mike Contarino , MD Internal Medicine and Pediatrics 1/22/10. Liver Injury Patterns. Hepatocellular Elevated aminotransferases +/- alk phos, bili Cholestasis Elevated alk phos, bili +/- aminotransferases Isolated Hyperbilirubinemia Jaundice if bili >2.5

tanaya
Télécharger la présentation

Toxic Hepatocellular Injury

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Toxic Hepatocellular Injury Mike Contarino, MD Internal Medicine and Pediatrics 1/22/10

  2. Liver Injury Patterns • Hepatocellular • Elevated aminotransferases +/- alk phos, bili • Cholestasis • Elevated alk phos, bili +/- aminotransferases • Isolated Hyperbilirubinemia • Jaundice if bili >2.5 • Infiltrative • Elevated Alk Phos; Bili/ALT/AST nl

  3. Hepatocellular Pattern • Viral Hepatitis: A, B, C, (ED), CMV, EBV, HSV, VZV • Autoimmune hepatitis • Drugs and Toxins: EtOH, Acetaminophen, Meds • NAFLD: Obese, DM, Hyperlipidemia • Vascular/Ischemic: Hypotension, CHF, Budd Chiari • Hereditary: Often systemic - Hemochromatosis, Alpha 1 antitrypsin def, Wilson’s Dx, Celiac

  4. Toxic Hepatocellular Injury • COMMON MEDS • ACETAMINOPHEN • NSAIDS • STATINS • ANTIBIOTICS (especially Amox/Clav)

  5. SOME SPECIFICS • ALT- more specific for liver than AST • >1000 indicative of ischemia, tylenol, severe viral hepatitis. • ALT> AST viral or fatty, AST:ALT >2:1 EtOH • Elevated LDH: ischemic or toxic

  6. Mechanism for drug excretion • Phase I and phase II reactions metabolize drugs • Phase I- Cytochrome P450 (oxidases, CYP3A4) • make polar for water solubility • Phase II- UDP glucoronyltransferases (UGT1, UGT2) • Products excreted via transport on canalicularor sinusoidal membranes (Phase III) • Transport into bile

  7. DILI- Drug Induced Liver Injury • Requires high index of suspicion • CLASSIFICATION: • Clinical: Hepatocellular, cholestatic, or mixed • Mechanism: Direct vs Idiosyncratic (immune/ metabolic) • Histology: Necrosis/apoptosis, Steatosis, Fibrosis, SOS (sinusoidal obstruction syndrome), Granulomatous

  8. Mechanism of DILI • Intrinsic hepatotoxins- dose dependent hepatocellular necrosis • Idiosyncratic reactions- most common • 0.01 to 1 percent of people taking drug • Allergic- hypersensitivity reaction • Metabolic- aberrant metabolism in susceptible pts

  9. VARIABLES • EtOH- CYP induction, GSH depletion • Diet- • CYP induction- Brussel sprouts, cabbage, broccoli, high protein diet • CYP inhibition- grapefruit juice, malnutrition • Other drugs- VAST!! • Alcohol and drugs do not mix! • Age- Decrease in CYP activity • Genetics, Underlying liver disease

  10. Sooo…. Our Patient • Markedly Elevated AST/ALT, mild AlkPhos, nlbili, Increased LDH • Toxic vs Ischemic • Not AST:ALT >2, No tylenol • ? In setting of early fatty liver, EtOH, and hx of paroxysmal atrial tachycardia • Biopsy: Stage 1 fibrosis of portal tracts, no steatosis or cholestasis, rare inflammatory cells. Resolving toxic-metabolic injury. • Ischemic 2/2 shock liver thought most likely • ? Holter monitor

More Related